Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.76 USD | -4.50% | -8.91% | -4.50% |
Feb. 12 | Acasti Pharma Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023 | CI |
Feb. 07 | Craig-Hallum Initiates Acasti Pharma With Buy Rating, $6 Price Target | MT |
- Stock Market
- Equities
- ACST Stock
- News Acasti Pharma Inc.
- MarketScreener Editorial Features